[252Cf brachytherapy].
Value of Californium 252 brachytherapy was discussed from our experience of 117 cases treated with either mold, interstitial or intracavitary application. Differentiated adenocarcinomas, malignant melanomas or recurrent cancers occurred in anoxic scar tissues were considered to be treated more effectively by Californium 252 fast neutron than photon radiation. Optimum absorbed neutron dose was 12-18 Gy. It should be modified depending on condition of surrounding normal tissue, because normal tissue tolerance limits to fast neutron may not be the same as photon radiation.
D001918:Brachytherapy / Q000379:methods; D002142:Californium / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008545:Melanoma / Q000532:radiotherapy; D009060:Mouth Floor; D009062:Mouth Neoplasms / Q000532:radiotherapy; D010159:Palate; D012878:Skin Neoplasms / Q000532:radiotherapy; D014062:Tongue Neoplasms / Q000532:radiotherapy; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy
D002142:Californium